Vizient (R) is proud to announce that the Vizient Clinical Data Base was recognized by Modern Healthcare as one of the Best in Business of 2025. The entire list of winners can be found in the Jan. 12, ...
Tina Eden, R.N., CEO of Virginia Gay Hospital, and Jacinda Bunch, Ph.D., R.N., assistant professor at the Iowa College of ...
In this conversation, Tina Eden, R.N., CEO of Virginia Gay Hospital, and Jacinda Bunch, Ph.D., R.N., assistant professor at ...
First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries– Investigator-Initiated (IIT) funded pancreatic and ...
| Servier is committing to rare neurology for the long term, using focused science and strategic collaborations to bring new ...
Cytovale(R) , a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced that it was ...
New investors include Pfizer Ventures and Apricot Capital with proceeds to advance pipeline and global expansionVibrant’s ...
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...
SHANGHAI and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ — Oricell Therapeutics Holdings Limited (“Oricell” or “the Company”), a global leader in innovative cancer immunotherapy, announced today the ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the early access launch of ...
MeMed, the leader in host-response diagnostics, announced it has been awarded a competitive national grant through the IIA to establish an acute-care diagnostics and proteomics biobank, as part of a ...
Zymeworks (ZYME) posts strong Phase 3 Ziihera data in HER2+ GEA and eyes up to $440M in milestones plus royalties—read the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback